Investing Profile

David Grayzel

Photo of David Grayzel, Partner at Atlas Venture
Your Intro Paths to David Grayzel
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find David Grayzel on

cb
Current Investing Position
Atlas Venture Partner
Investment Range
$500K - $5.0M
Sweet Spot
$2.0M
Investments On Record
9

David Grayzel is on these Sector & Stage Rankings

David Grayzel's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Trace Neuroscience
Series ANov 2024$100M
$100M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Jeffrey Tong (Third Rock Ventures)
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
Series AMay 2020$46M
$150M
Co-investors: Diyong Xu (OrbiMed), Isaac Manke (Acorn Bioventures)
Comanche Biopharma
Series BJan 2024$75M
$75M
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA))
Triana Biomedicines
Series AApr 2022$110M
$110M
Co-investors: Christopher O'Donnell (Pfizer Venture Investments)
Affinia Therapeutics
Series BMay 2021$110M
Series AMar 2020$60M
$170M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Robert Weisskoff (F-Prime Capital Partners)
Delinia
Series ASep 2016$35M
$35M